ALEXION PHARMACEUTICALS INC (ALXN) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 1000 transactions totaling $717.8M, demonstrating a bearish sentiment with -$164.6M in net insider flow. The most recent transaction on Jul 21, 2021 involved a transaction of 146,511 shares valued at $0.
No significant insider buying has been recorded for ALXN in the recent period.
No significant insider selling has been recorded for ALXN in the recent period.
Based on recent SEC filings, insider sentiment for ALXN is bearish with an Insider Alignment Score of 39/100 and a net flow of -$164.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ALEXION PHARMACEUTICALS INC (ALXN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading ALXN stock, having executed 1000 transactions in the past 90 days. The most active insider is Leonard Bell (Executive), who has made 185 transactions totaling $283.3M.
Get notified when executives and directors at ALXN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 21, 2021 | J. Orloff John | Executive | Disposition | 146,511 | $N/A | $0 | |
| Jul 21, 2021 | Hantson Ludwig | Executive | Disposition | 580,809 | $N/A | $0 | |
| Jul 21, 2021 | Rummelt Andreas | Executive | Disposition | 28,109 | $N/A | $0 | |
| Jul 21, 2021 | Nader Francois | Executive | Disposition | 13,921 | $N/A | $0 | |
| Jul 21, 2021 | Lall Franchini Indrani | Executive | Disposition | 116,075 | $N/A | $0 | |
| Jul 21, 2021 | Bazarko Daniel | Executive | Disposition | 60,207 | $N/A | $0 | |
| Jul 21, 2021 | Chiniara Ellen | Executive | Disposition | 116,850 | $N/A | $0 | |
| Jul 21, 2021 | Goff Brian | Executive | Disposition | 150,832 | $N/A | $0 | |
| Jul 21, 2021 | R. Brennan David | Executive | Disposition | 20,873 | $N/A | $0 | |
| Jul 21, 2021 | T. Mollen John | Executive | Disposition | 15,336 | $N/A | $0 | |
| Jul 21, 2021 | Carino Tanisha | Executive | Disposition | 59,226 | $N/A | $0 | |
| Jul 21, 2021 | Dunsire Deborah | Executive | Disposition | 14,629 | $N/A | $0 | |
| Jul 21, 2021 | A. Reinsdorf Judith | Executive | Disposition | 14,150 | $N/A | $0 | |
| Jul 21, 2021 | A. Friedman Paul | Executive | Disposition | 12,840 | $N/A | $0 | |
| Jul 21, 2021 | Sarin Aradhana | Executive | Disposition | 120,253 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 483 | $441.2M | 54.3% |
Purchase(P) | 89 | $276.6M | 34.0% |
Exercise(M) | 75 | $49.9M | 6.1% |
Payment(F) | 62 | $41.6M | 5.1% |
Award(A) | 269 | $3.7M | 0.5% |
Disposition(D) | 16 | $0 | 0.0% |
Gift(G) | 6 | $0 | 0.0% |
Insider selling pressure at ALEXION PHARMACEUTICALS INC has increased, with 46 insiders executing 1000 transactions across all time. Total sales of $441.2M significantly outpace purchases of $276.6M, resulting in a net outflow of $164.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.